South Korea - Obstructive Airway Diseases Medicine Use
Since 2014, South Korea Obstructive Airway Diseases Medicine Use decreased by 1.3% year on year. In 2019, the country was number 27 among other countries in Obstructive Airway Diseases Medicine Use at 13.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. South Korea is overtaken by Chile, which was number 26 at 19.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Latvia with 6.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. United Kingdom topped the ranking with 96.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +1.4% versus 2018. Finland, Norway and Denmark respectively ranked number 2, 3 and 4 in this ranking. Austria recorded the best 5 years average growth at +7.6% per year, while Latvia witnessed the worst performance at -5.6% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 13.20 |
2018 | 13.20 |
2017 | 12.90 |
2016 | 14.30 |
2015 | 15.50 |
How does South Korea rank in Obstructive Airway Diseases Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United Kingdom
|
96 | 2019 | +1.4 % | +0.3 % | View data | |
2 |
#2
Finland
|
80 | 2019 | +1.7 % | +2.8 % | View data | |
26 |
#26
Chile
|
19 | 2019 | +25.3 % | +7.3 % | View data | |
27 |
#27
South Korea
|
13 | 2019 | +0.0 % | -1.3 % | View data | |
28 |
#28
Latvia
|
7 | 2019 | +1.5 % | -5.6 % | View data |